Published in Mol Cell Pharmacol on January 01, 2010
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget (2012) 1.33
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget (2014) 0.97
The Role of INDY in Metabolic Regulation. Comput Struct Biotechnol J (2013) 0.89
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Sci Rep (2015) 0.85
Genetic induction of the Warburg effect inhibits tumor growth. Oncotarget (2012) 0.83
Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission. J Neuromuscul Dis (2016) 0.81
The physiological role of drug transporters. Protein Cell (2015) 0.80
Model-Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target. CPT Pharmacometrics Syst Pharmacol (2016) 0.76
Acute versus chronic supplementation of sodium citrate on 200 m performance in adolescent swimmers. J Int Soc Sports Nutr (2014) 0.75
ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75
Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature (2002) 8.45
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Extended life-span conferred by cotransporter gene mutations in Drosophila. Science (2000) 4.62
Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature (2007) 4.60
Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature (2007) 4.29
Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature (2003) 4.27
How does calorie restriction work? Genes Dev (2003) 3.73
Caloric restriction and aging: an update. Exp Gerontol (2000) 3.07
The supply of precursors for the synthesis of fatty acids. J Biol Chem (1962) 2.08
MPEx: a tool for exploring membrane proteins. Protein Sci (2009) 1.89
Functional characterization and immunolocalization of the transporter encoded by the life-extending gene Indy. Proc Natl Acad Sci U S A (2002) 1.80
Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem (1985) 1.75
Long-lived Indy and calorie restriction interact to extend life span. Proc Natl Acad Sci U S A (2009) 1.63
Kinetic study of the tricarboxylate carrier in rat liver mitochondria. Eur J Biochem (1972) 1.61
Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid. Biochemistry (2009) 1.61
Citrate and the conversion of carbohydrate into fat. Fatty acid synthesis by a combination of cytoplasm and mitochondria. J Biol Chem (1970) 1.59
Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage. Proc Natl Acad Sci U S A (2009) 1.42
Human Na+ -coupled citrate transporter: primary structure, genomic organization, and transport function. Biochem Biophys Res Commun (2002) 1.40
Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. Biochem J (2004) 1.38
Incorporation of radioactive citrate into fatty acids. Biochim Biophys Acta (1962) 1.37
Functional identity of Drosophila melanogaster Indy as a cation-independent, electroneutral transporter for tricarboxylic acid-cycle intermediates. Biochem J (2002) 1.37
Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem (2002) 1.27
High level expression and characterization of the mitochondrial citrate transport protein from the yeast Saccharomyces cerevisiae. J Biol Chem (1995) 1.23
The yeast mitochondrial ADP/ATP carrier functions as a monomer in mitochondrial membranes. Proc Natl Acad Sci U S A (2007) 1.15
Donepezil: a review of its use in Alzheimer's disease. Drugs Aging (2000) 1.11
The life-extending gene Indy encodes an exchanger for Krebs-cycle intermediates. Biochem J (2006) 1.11
Structure and function of mitochondrial anion transport proteins. J Membr Biol (2001) 1.10
The yeast mitochondrial citrate transport protein. Probing the roles of cysteines, Arg(181), and Arg(189) in transporter function. J Biol Chem (2000) 1.09
Factors affecting the kinetics and equilibrium of exchange reactions of the citrate-transporting system of rat liver mitochondria. J Biol Chem (1971) 1.08
Purification and characterization of the reconstitutively active tricarboxylate transporter from rat liver mitochondria. J Biol Chem (1990) 1.07
Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates. Biochem J (2004) 1.04
Identification of the substrate binding sites within the yeast mitochondrial citrate transport protein. J Biol Chem (2007) 0.99
Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines. Am J Physiol Gastrointest Liver Physiol (2006) 0.99
Oligomeric state of wild-type and cysteine-less yeast mitochondrial citrate transport proteins. J Bioenerg Biomembr (1999) 0.96
The sensitivity of the exchange reactions of tricarboxylate, 2-oxoglutarate and dicarboxylate transporting systems of rat liver mitochondria to inhibition by 2-pentylmalonate, p-iodobenzylmalonate, and benzene 1,2,3-tricarboxylate. Eur J Biochem (1971) 0.96
Homology-modeled structure of the yeast mitochondrial citrate transport protein. Biophys J (2004) 0.94
High-yield bacterial expression, purification, and functional reconstitution of the tricarboxylate transport protein from rat liver mitochondria. Biochem Biophys Res Commun (1995) 0.93
Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor. Mol Pharmacol (2009) 0.88
Yeast mitochondrial ADP/ATP carriers are monomeric in detergents as demonstrated by differential affinity purification. J Mol Biol (2007) 0.86
Structure, function and regulation of the tricarboxylate transport protein from rat liver mitochondria. J Bioenerg Biomembr (1993) 0.82
Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance. J Med Chem (2006) 1.75
Properties of two cataract-associated mutations located in the NH2 terminus of connexin 46. Am J Physiol Cell Physiol (2013) 1.46
Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J Biol Chem (2010) 1.36
Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci U S A (2012) 1.10
A strategy for identification and quantification of detergents frequently used in the purification of membrane proteins. Anal Biochem (2003) 1.10
Ion selectivity of alpha-hemolysin with beta-cyclodextrin adapter. II. Multi-ion effects studied with grand canonical Monte Carlo/Brownian dynamics simulations. J Phys Chem B (2010) 1.02
Identification of the substrate binding sites within the yeast mitochondrial citrate transport protein. J Biol Chem (2007) 0.99
Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. J Med Chem (2010) 0.98
Homology-modeled structure of the yeast mitochondrial citrate transport protein. Biophys J (2004) 0.94
Ion selectivity of alpha-hemolysin with a beta-cyclodextrin adapter. I. Single ion potential of mean force and diffusion coefficient. J Phys Chem B (2010) 0.92
An intersubunit salt bridge near the selectivity filter stabilizes the active state of Kir1.1. Biophys J (2009) 0.92
The yeast mitochondrial citrate transport protein: characterization of transmembrane domain III residue involvement in substrate translocation. J Biol Chem (2004) 0.91
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. J Med Chem (2005) 0.90
External K activation of Kir1.1 depends on the pH gate. Biophys J (2007) 0.88
Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor. Mol Pharmacol (2009) 0.88
Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands. Org Biomol Chem (2014) 0.86
A conserved arginine near the filter of Kir1.1 controls Rb/K selectivity. Channels (Austin) (2011) 0.85
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands. Bioorg Med Chem Lett (2006) 0.85
The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity. J Biol Chem (2010) 0.82
Binding of glutamate to the umami receptor. Biophys Chem (2010) 0.80
Introduction of the chloroplast redox regulatory region in the yeast ATP synthase impairs cytochrome c oxidase. J Biol Chem (2008) 0.80
The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues. Biochim Biophys Acta (2006) 0.79
Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy. Bioorg Med Chem Lett (2002) 0.79
Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. Bioorg Med Chem Lett (2009) 0.78
Molecular dynamics study of a polymeric reverse osmosis membrane. J Phys Chem B (2009) 0.78
Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach. J Bioenerg Biomembr (2010) 0.77
Moving the pH gate of the Kir1.1 inward rectifier channel. Channels (Austin) (2009) 0.77
The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate. J Bioenerg Biomembr (2008) 0.76
Presence of the anti-leukemic nucleotide analog, 2-chloro-2'-deoxyadenosine-5'-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP). Arch Biochem Biophys (2007) 0.75
2-Chloro-2'-deoxyadenosine: alteration of DNA:TATA element binding protein (TBP) interactions. J Mol Model (2003) 0.75
Analysis of the secondary structure of the cys-less yeast mitochondrial citrate transport protein and four single-cys variants by circular dichroism. J Bioenerg Biomembr (2004) 0.75